High costs for diagnosis, care of nonalcoholic fatty liver disease

June 11, 2018

(HealthDay)—The health care costs associated with nonalcoholic fatty liver disease (NAFLD) are considerable, especially at first diagnosis, according to a study published online May 18 in Hepatology.

Alina M. Allen, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues examined the total cost and resource utilization associated with a new NAFLD using U.S. medical and pharmacy claims data from OptumLabs Data Warehouse. A total of 152,064 adults with a first claim for NAFLD were identified, of whom 108,420 were matched to non-NAFLD contemporary controls in a 1:1 ratio. Participants were followed for a median of 2.6 years.

The researchers found that per NAFLD patient with private insurance, the total annual cost of care was $7,804 and $3,789 for a new diagnosis and for long-term management, respectively. These were significantly higher than the total annual costs per matched control with similar comorbidities ($2,298). The largest increases in health care utilization were represented by liver biopsies, imaging, and hospitalizations (relative risks, 55.0, 3.95, and 1.87, respectively), which may account for the increased costs in NAFLD versus controls.

"The costs associated with the care for NAFLD independent of its metabolic comorbidities are very high, especially at first diagnosis," the authors write. "Research efforts should focus on identification of underlying determinants of use, sources of excess cost, and development of cost-effective diagnostic tests."

Explore further: Germany: compensated cirrhosis substantially increases comorbidities and healthcare costs

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Germany: compensated cirrhosis substantially increases comorbidities and healthcare costs

April 13, 2018
An analysis of outcomes and costs for German patients with non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) who develop compensated cirrhosis was presented today at The International Liver Congress ...

Guidelines updated for diagnosis, management of NAFLD

July 19, 2017
(HealthDay)—A practice guidance statement, published online July 17 in Hepatology, has been developed to augment the clinical practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease (NAFLD).

NAFLD not independently tied to risk of reflux esophagitis

December 12, 2017
(HealthDay)—Nonalcoholic fatty liver disease (NAFLD) is not associated with increased risk of incident reflux esophagitis after adjustment for variables, including body mass index (BMI), according to a study published online ...

NAFLD independently linked to cardiovascular disease

June 7, 2012
(HealthDay) -- Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk of cardiovascular disease (CVD), but it is not associated with a statistically significantly increased risk of cardiovascular ...

Recommendations developed for pediatric NAFLD

December 13, 2016
(HealthDay)—Evidence-based recommendations have been developed for screening, diagnosis, and treatment of pediatric nonalcoholic fatty liver disease (NAFLD). The guidelines were published online Nov. 30 in the Journal of ...

Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

June 19, 2017
Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by abnormal accumulation of fat in the liver. NAFLD is diagnosed in up to one in three adults and one in 10 children in the United States, and obesity ...

Recommended for you

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.